<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="hsr270495" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Health Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Health Sci Rep</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2398-8835</journal-id><journal-id journal-id-type="publisher-id">HSR2</journal-id><journal-title-group><journal-title>Health Science Reports</journal-title></journal-title-group><issn pub-type="epub">2398-8835</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39980831</article-id><article-id pub-id-type="pmc">PMC11839489</article-id>
<article-id pub-id-type="doi">10.1002/hsr2.70495</article-id><article-id pub-id-type="publisher-id">HSR270495</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Association of <italic toggle="yes">SIRT1</italic> rs3758391 Polymorphism With T2DM in Bangladeshi Population: Evidence From a Case&#x02010;Control Study and Meta&#x02010;Analysis</article-title></title-group><contrib-group><contrib id="hsr270495-cr-0001" contrib-type="author" corresp="yes"><name><surname>Ahmed</surname><given-names>Rezwana</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0006-9350-5033</contrib-id><xref rid="hsr270495-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>rezwana.ahmed01@northsouth.edu</email></address></contrib><contrib id="hsr270495-cr-0002" contrib-type="author"><name><surname>Safa</surname><given-names>Mushfikur Rahman</given-names></name><xref rid="hsr270495-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hsr270495-cr-0003" contrib-type="author"><name><surname>Zahid</surname><given-names>Zahidul Islam</given-names></name><xref rid="hsr270495-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hsr270495-cr-0004" contrib-type="author"><name><surname>Chowdhury</surname><given-names>Md. Mazharul Islam</given-names></name><xref rid="hsr270495-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="hsr270495-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hsr270495-cr-0005" contrib-type="author"><name><surname>Hasan</surname><given-names>A.B.M. Kamrul</given-names></name><xref rid="hsr270495-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="hsr270495-cr-0006" contrib-type="author"><name><surname>Mostaid</surname><given-names>Md. Shaki</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9229-651X</contrib-id><xref rid="hsr270495-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hsr270495-cr-0007" contrib-type="author" corresp="yes"><name><surname>Reza</surname><given-names>Hasan Mahmud</given-names></name><xref rid="hsr270495-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>hasan.reza@northsouth.edu</email></address></contrib></contrib-group><aff id="hsr270495-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Pharmaceutical Sciences</named-content>
<institution>North South University</institution>
<city>Dhaka</city>
<country country="BD">Bangladesh</country>
</aff><aff id="hsr270495-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>Appalachian College of Pharmacy</institution>
<city>Oakwood</city>
<named-content content-type="country-part">Georgia</named-content>
<country country="US">USA</country>
</aff><aff id="hsr270495-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Endocrinology</named-content>
<institution>Mymensingh Medical College</institution>
<city>Mymensingh</city>
<country country="BD">Bangladesh</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold> Rezwana Ahmed (<email>rezwana.ahmed01@northsouth.edu</email>)<break/>
Hasan Mahmud Reza (<email>hasan.reza@northsouth.edu</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>8</volume><issue seq="47">2</issue><issue-id pub-id-type="doi">10.1002/hsr2.v8.2</issue-id><elocation-id>e70495</elocation-id><history>
<date date-type="rev-recd"><day>22</day><month>10</month><year>2024</year></date>
<date date-type="received"><day>05</day><month>4</month><year>2024</year></date>
<date date-type="accepted"><day>04</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Health Science Reports</italic> published by Wiley Periodicals LLC.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:HSR2-8-e70495.pdf"/><abstract><title>ABSTRACT</title><sec id="hsr270495-sec-0010"><title>Background and Aim</title><p>Type 2 diabetes mellitus (T2DM) remains one of the major causes of morbidity and mortality worldwide, including Bangladesh. SIRT1, an NAD&#x02010;dependent deacetylase, is involved in energy homeostasis and protects &#x003b2;&#x02010;cells of the pancreas from oxidative stress. Single nucleotide polymorphisms (SNPs) in the <italic toggle="yes">SIRT1</italic> gene have been found to be associated with T2DM in several populations, however, with conflicting results. The aim of this present case&#x02010;control study, along with the meta&#x02010;analysis, was to elucidate the association of rs3758391 polymorphism with the susceptibility to T2DM in Bangladeshi population.</p></sec><sec id="hsr270495-sec-0020"><title>Methods</title><p>72 T2DM patients and 90 healthy controls were enrolled in our study and polymerase chain reaction&#x02010;restriction fragment length polymorphism (PCR&#x02010;RFLP) was employed for genotyping the SNP. Odds ratio (OR) with 95% confidence interval (95% CI) was used to represent the association of <italic toggle="yes">SIRT1</italic> polymorphism with T2DM. For the meta&#x02010;analysis six studies were included and pooled odds ratio with 95% CI were calculated for six genetic models using the random effects model. Heterogeneity and publication bias was also calculated for each study.</p></sec><sec id="hsr270495-sec-0030"><title>Results</title><p>A significant association was found between rs3758391 polymorphism and increased risk of T2DM under codominant TT versus CC (OR&#x02009;=&#x02009;3.88, 95% CI&#x02009;=&#x02009;1.34&#x02013;11.25, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.012), recessive TT versus CC&#x02009;+&#x02009;CT (OR&#x02009;=&#x02009;2.83, 95% CI&#x02009;=&#x02009;1.12&#x02013;7.09, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.027) and allelic T versus C (OR&#x02009;=&#x02009;1.67, 95% CI&#x02009;=&#x02009;1.07&#x02013;2.60, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.024) genetic models. However, no significant association between rs3758391 and other biochemical and anthropometric parameters were found. Our meta&#x02010;analysis showed no statistically significant association of this polymorphism.</p></sec><sec id="hsr270495-sec-0040"><title>Conclusion</title><p>We conclude that, polymorphism at rs3758391 of <italic toggle="yes">SIRT1</italic> gene conferred an increased risk of T2DM in Bangladeshi population.</p></sec></abstract><kwd-group><kwd id="hsr270495-kwd-0001">Bangladesh</kwd><kwd id="hsr270495-kwd-0002">risk</kwd><kwd id="hsr270495-kwd-0003">rs3578391</kwd><kwd id="hsr270495-kwd-0004">SIRT1</kwd><kwd id="hsr270495-kwd-0005">type 2 diabetes mellitus</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>The research was supported by research grant (CTRGC&#x02010;20/SHLS/31) from North South University.</funding-source></award-group></funding-group><counts><fig-count count="4"/><table-count count="7"/><page-count count="12"/><word-count count="6359"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>February 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:26.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="hsr270495-sec-0050"><label>1</label><title>Introduction</title><p>Among the noncommunicable diseases, diabetes mellitus (DM) remains one of the major causes of death and disabilities globally. About 529 million people were living with DM worldwide in the year 2021 and this figure is estimated to reach 1.31 billion by 2050 [<xref rid="hsr270495-bib-0001" ref-type="bibr">1</xref>]. Type 2 diabetes mellitus (T2DM), forms the bulk of DM, which in 2021 accounted for 96% of the total DM prevalence [<xref rid="hsr270495-bib-0001" ref-type="bibr">1</xref>]. T2DM is characterized by hyperglycemia, caused primarily by defects in insulin secretion by the &#x003b2;&#x02010;cells of the pancreas and resistance of the target tissues to the effects of insulin [<xref rid="hsr270495-bib-0002" ref-type="bibr">2</xref>]. Inflammation, adipokine dysregulation, abnormalities in the gut microbiota, immune dysregulation and excessive reactive oxygen species generation serve as important pathophysiological factors in the development of T2DM [<xref rid="hsr270495-bib-0003" ref-type="bibr">3</xref>, <xref rid="hsr270495-bib-0004" ref-type="bibr">4</xref>]. In addition, obesity, high&#x02010;calorie diet and sedentary lifestyle are the major factors that drive T2DM epidemic in this modern society [<xref rid="hsr270495-bib-0005" ref-type="bibr">5</xref>, <xref rid="hsr270495-bib-0006" ref-type="bibr">6</xref>]. Notably, genetic factors play a significant role in the development of T2DM, and several genetic loci have been identified by genome wide&#x02010;association studies that increase the risk of T2DM [<xref rid="hsr270495-bib-0007" ref-type="bibr">7</xref>, <xref rid="hsr270495-bib-0008" ref-type="bibr">8</xref>].</p><p>Sirtuins are a family of nicotinamide adenine dinucleotide (NAD)&#x02013;dependent protein deacetylases [<xref rid="hsr270495-bib-0009" ref-type="bibr">9</xref>, <xref rid="hsr270495-bib-0010" ref-type="bibr">10</xref>], and sirtuin 1 (SIRT1) is the most notable and studied one amongst them. Several proteins are the targets of SIRT1, such as those that are important in energy metabolism [<xref rid="hsr270495-bib-0011" ref-type="bibr">11</xref>, <xref rid="hsr270495-bib-0012" ref-type="bibr">12</xref>, <xref rid="hsr270495-bib-0013" ref-type="bibr">13</xref>, <xref rid="hsr270495-bib-0014" ref-type="bibr">14</xref>], DNA repair [<xref rid="hsr270495-bib-0015" ref-type="bibr">15</xref>], and inflammation [<xref rid="hsr270495-bib-0016" ref-type="bibr">16</xref>]. SIRT1 is expressed in tissues that are important in metabolism such as the pancreas, liver, adipose tissue, heart, brain, and muscle [<xref rid="hsr270495-bib-0017" ref-type="bibr">17</xref>]. It plays essential roles in nutrient&#x02010;sensing and insulin signaling pathways, including stress responses with consequent effects on cellular proliferation, survival, and apoptosis [<xref rid="hsr270495-bib-0018" ref-type="bibr">18</xref>]. During calorie restriction, increased expression of SIRT1 occurs that contributes to delaying the onset of diseases of aging such as diabetes, atherosclerosis, and cancer [<xref rid="hsr270495-bib-0019" ref-type="bibr">19</xref>, <xref rid="hsr270495-bib-0020" ref-type="bibr">20</xref>]. Accumulating evidence suggests that SIRT1 regulates glucose and lipid metabolism, as well as improving the sensitivity of the skeletal muscle, liver, and adipose tissues to the effects of insulin [<xref rid="hsr270495-bib-0021" ref-type="bibr">21</xref>]. In addition, it exerts positive effects on pancreatic beta cells' function and mass [<xref rid="hsr270495-bib-0021" ref-type="bibr">21</xref>], more specifically, it plays important roles in the glucose&#x02010;ATP signaling and insulin secretion from the pancreatic beta cells [<xref rid="hsr270495-bib-0022" ref-type="bibr">22</xref>, <xref rid="hsr270495-bib-0023" ref-type="bibr">23</xref>]. Moreover, overexpression of SIRT1 or using SIRT1 activators in mice models improved glucose homeostasis and insulin sensitivity [<xref rid="hsr270495-bib-0024" ref-type="bibr">24</xref>, <xref rid="hsr270495-bib-0025" ref-type="bibr">25</xref>, <xref rid="hsr270495-bib-0026" ref-type="bibr">26</xref>, <xref rid="hsr270495-bib-0027" ref-type="bibr">27</xref>]. Consequently, SIRT1 dysregulation has been implicated in diabetes and thereby, it may be considered as a therapeutic target for some debilitating diseases, for example, neurodegeneration, osteoarthritis, cardiovascular disease, and diabetic complications [<xref rid="hsr270495-bib-0017" ref-type="bibr">17</xref>, <xref rid="hsr270495-bib-0028" ref-type="bibr">28</xref>, <xref rid="hsr270495-bib-0029" ref-type="bibr">29</xref>, <xref rid="hsr270495-bib-0030" ref-type="bibr">30</xref>, <xref rid="hsr270495-bib-0031" ref-type="bibr">31</xref>, <xref rid="hsr270495-bib-0032" ref-type="bibr">32</xref>, <xref rid="hsr270495-bib-0033" ref-type="bibr">33</xref>, <xref rid="hsr270495-bib-0034" ref-type="bibr">34</xref>]. Therefore, <italic toggle="yes">SIRT1</italic> serves as a plausible candidate gene that needs to be investigated to assess the relationship between <italic toggle="yes">SIRT1</italic> and susceptibility to T2DM. Furthermore, quite a few single nucleotide polymorphisms (SNPs) of the <italic toggle="yes">SIRT1</italic> gene have already been suggested to be involved in the increased risk of T2DM.</p><p>The location of the <italic toggle="yes">SIRT1</italic> gene is in chromosome 10q21.3, consisting of nine exons and eight introns [<xref rid="hsr270495-bib-0035" ref-type="bibr">35</xref>]. The SNP rs3758391 resides in the promoter region of the <italic toggle="yes">SIRT1</italic> gene. Recently some studies have reported the effect of rs3758391 SNP on T2DM susceptibility, however, the results have been largely inconsistent. Sadeghi et al. reported that polymorphism of rs3758391 conferred a protective effect for T2DM in the Iranian population [<xref rid="hsr270495-bib-0036" ref-type="bibr">36</xref>], whereas, an increased risk was reported by Faradonbeh et al. and Cruz et al. in the Iranian and Mexican population, respectively [<xref rid="hsr270495-bib-0037" ref-type="bibr">37</xref>, <xref rid="hsr270495-bib-0038" ref-type="bibr">38</xref>]. However, no significant association was found between rs3758391 and susceptibility to T2DM in the Chinese population by Peng et al. [<xref rid="hsr270495-bib-0039" ref-type="bibr">39</xref>]. This finding was further corroborated by two studies in Indian and Finnish population where they also reported negative association for this polymorphism [<xref rid="hsr270495-bib-0040" ref-type="bibr">40</xref>, <xref rid="hsr270495-bib-0041" ref-type="bibr">41</xref>]. Hence, under these circumstances, we aimed to evaluate the association between <italic toggle="yes">SIRT1</italic> rs3758391 polymorphism and T2DM in a sample of Bangladeshi population and assess how our findings compare with the previous results. Moreover, we assessed the correlation of the SNP with the clinical parameters. In addition, we performed a meta&#x02010;analysis of the previous studies and compared it with our findings to further investigate the association of this SNP with T2DM.</p></sec><sec sec-type="materials-and-methods" id="hsr270495-sec-0060"><label>2</label><title>Materials and Methods</title><sec id="hsr270495-sec-0070"><label>2.1</label><title>Study Subjects and Anthropometric Measurements</title><p>This case&#x02010;control study consisted of 72 T2DM patients and 90 healthy controls. All the patients were recruited from different specialized diabetic hospitals in Dhaka city between November 2021 and January 2023. An expert endocrinologist at the concerned center confirmed the diabetes diagnosis according to the International Diabetes Federation (IDF) criteria, that is, fasting blood glucose concentration&#x02009;&#x02265;&#x02009;6.1&#x02009;mmol/l or HbA1c&#x02009;&#x02265;&#x02009;6.5%. Age and gender matched healthy controls were recruited and they were confirmed of having no T2DM by the same diagnostic procedures as the cases. Exclusion criteria for the study subjects were as follows: pregnant and lactating women, subjects with T1DM, prediabetes and other endocrine dysfunctions. In addition, subjects with chronic diseases such as chronic liver disease, kidney disease unrelated to T2DM, autoimmune diseases or cancer were also excluded. The G*Power software was used to perform the post&#x02010;hoc power calculation [<xref rid="hsr270495-bib-0042" ref-type="bibr">42</xref>]. Using the z&#x02010;test and logistic regression for a sample size of 162, odds ratio of 3.88, &#x003b1; error&#x02009;=&#x02009;0.05 and binomial distribution, our study achieved a power (1&#x02010;&#x003b2;)&#x02009;=&#x02009;97.6% with a critical z&#x02009;=&#x02009;1.96. Ethical approval for the study protocol was obtained from the ethical review committee at North South University (#2020/OR&#x02010;NSU/IRB/1202). Before participation in the study, all study participants signed the informed consent form. Anthropometric data were collected from their medical records and personal interview.</p></sec><sec id="hsr270495-sec-0080"><label>2.2</label><title>Blood Sample Collection, Biochemical Measurements, and DNA Extraction</title><p>A total of 5&#x02009;mL of venous blood was collected from the study participants into K&#x02010;EDTA tubes and the blood was stored at &#x02212;80&#x000b0;C until further analysis was done. The biochemical analyses such as high&#x02010;density lipoprotein (HDL), low&#x02010;density lipoprotein (LDL), triglyceride (TG), total cholesterol (TC), and glycemic indices (glycated hemoglobin, HbA1c, fasting blood glucose, FBG; postprandial blood glucose, PPG) were performed using Humalyzer 3000 semi&#x02010;automatic biochemistry analyzer using the specific kit protocols at the North South University pathology center.</p><p>Genomic DNA was extracted from 200&#x02009;&#x000b5;l of whole blood using a blood genomic DNA extraction kit (Favorgen, Taiwan) following the manufacturer's instructions. The purity and concentration of the extracted DNA was analyzed using NanoDrop microvolume spectrophotometer (Thermo Fisher Scientific, USA), with the absorbance ratio set at 260/280&#x02009;nm. The DNA extracted was stored at &#x02212;20&#x000b0;C until further analysis was done.</p></sec><sec id="hsr270495-sec-0090"><label>2.3</label><title>Genotyping Using Restriction Fragment Length Polymorphism (RFLP) Technique</title><p>The genotyping of the rs3758391 polymorphism was performed by utilizing the polymerase chain reaction&#x02010;restriction fragment length polymorphism (PCR&#x02010;RFLP) technique. The PCR primers had the following sequence, Forward: 5&#x02032;&#x02010;GTCACGCAGGTAATTGATGCAG&#x02010;3&#x02032; and Reverse: 5&#x02032;&#x02010;GGCTTAGTGGAAAGCCCTTC&#x02010;3&#x02032;, according to a previous study [<xref rid="hsr270495-bib-0036" ref-type="bibr">36</xref>]. PCR was performed in a 20&#x02009;&#x000b5;L reaction volume consisting of 100&#x02009;ng of the DNA sample, 1&#x02009;&#x003bc;L of forward and 1&#x02009;&#x003bc;L of reverse primers, 10&#x02009;&#x003bc;L of 2x PCR Mastermix (New England Biolabs, USA) and nuclease&#x02010;free water up to 20&#x02009;&#x003bc;L. The conditions for the reactions were: initial denaturation for 3&#x02009;min at 94&#x000b0;C followed by 30 cycles of denaturation at 94&#x000b0;C for 30&#x02009;s, annealing at 57&#x000b0;C for 30&#x02009;s, and extension at 72&#x000b0;C for 30&#x02009;s, followed by a final extension for 5&#x02009;min at 72&#x000b0;C. The PCR amplicons were analyzed on 1.5% agarose gels containing ethidium bromide to ensure the correct amplicon size of 241&#x02009;bp. After confirmation of the desired amplicon size, 10&#x02009;&#x003bc;L of the PCR product was digested with the restriction enzyme NlaIII (New England Biolabs, USA) at 37&#x000b0;C for 1&#x02009;h. The digested products were visualized on a 2% agarose gel stained with ethidium bromide. A DNA ladder of 100&#x02009;bp was utilized for the size estimation of the DNA fragments. The TT genotype yielded bands of 148&#x02009;bp and 93&#x02009;bp, the CC genotype yielded a band of 241&#x02009;bp, while the CT genotype yielded bands of 241&#x02009;bp, 148&#x02009;bp, and 93&#x02009;bp (Figure&#x000a0;<xref rid="hsr270495-fig-0001" ref-type="fig">1</xref>).</p><fig position="float" fig-type="Figure" id="hsr270495-fig-0001"><label>Figure 1</label><caption><p>Restriction fragment length polymorphism analysis of rs3758391 C/T single&#x02010;nucleotide polymorphism (SNP) using NlaIII enzyme. 100&#x02010;bp ladder: Lane M; CC (241&#x02009;bp): Lane14; TT (148&#x02009;bp and 93&#x02009;bp): Lane 2, 5, 6, 7, 10, 11; CT (241&#x02009;bp, 148&#x02009;bp, and 93&#x02009;bp): Lane 1, 3, 4, 8, 9, 12, 13.</p></caption><graphic xlink:href="HSR2-8-e70495-g001" position="anchor" id="jats-graphic-1"/></fig></sec><sec id="hsr270495-sec-0100"><label>2.4</label><title>Meta&#x02010;Analysis Methodology</title><sec id="hsr270495-sec-0110"><label>2.4.1</label><title>Identification of the Relevant Studies</title><p>PubMed, Google Scholar, and Embase was searched comprehensively to find relevant articles related to rs3758391 gene polymorphism and T2DM using keywords: &#x0201c;SIRT1,&#x0201d; &#x0201c;type II diabetes,&#x0201d; &#x0201c;rs3758391,&#x0201d; &#x0201c;type 2 diabetes,&#x0201d; &#x0201c;polymorphism,&#x0201d; &#x0201c;risk,&#x0201d; &#x0201c;association,&#x0201d; (Table&#x000a0;<xref rid="hsr270495-tbl-0001" ref-type="table">1</xref>). We performed the meta&#x02010;analysis using the PRISMA&#x02010;P guidelines [<xref rid="hsr270495-bib-0043" ref-type="bibr">43</xref>], (Figure&#x000a0;<xref rid="hsr270495-fig-0002" ref-type="fig">2</xref>).</p><table-wrap position="float" id="hsr270495-tbl-0001" content-type="Table"><label>Table 1</label><caption><p>Search query and found initial articles.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Website</th><th align="center" valign="bottom" rowspan="1" colspan="1">Search query</th><th align="center" valign="bottom" rowspan="1" colspan="1">Articles found</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">PubMed</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0201c;SIRT1,&#x0201d; &#x0201c;type II diabetes,&#x0201d; &#x0201c;rs3758391,&#x0201d; &#x0201c;type 2 diabetes,&#x0201d; &#x0201c;polymorphism,&#x0201d; &#x0201c;risk,&#x0201d; &#x0201c;association&#x0201d;</td><td align="center" valign="top" rowspan="1" colspan="1">32</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Google Scholar</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0201c;SIRT1,&#x0201d; &#x0201c;type II diabetes,&#x0201d; &#x0201c;rs3758391,&#x0201d; &#x0201c;type 2 diabetes,&#x0201d; &#x0201c;polymorphism,&#x0201d; &#x0201c;risk,&#x0201d; &#x0201c;association&#x0201d;</td><td align="center" valign="top" rowspan="1" colspan="1">103</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Embase</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0201c;SIRT1,&#x0201d; &#x0201c;type II diabetes,&#x0201d; &#x0201c;rs3758391,&#x0201d; &#x0201c;type 2 diabetes,&#x0201d; &#x0201c;polymorphism,&#x0201d; &#x0201c;risk,&#x0201d; &#x0201c;association&#x0201d;</td><td align="center" valign="top" rowspan="1" colspan="1">28</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><fig position="float" fig-type="Figure" id="hsr270495-fig-0002"><label>Figure 2</label><caption><p>PRISMA&#x02010;P flowchart showing the selection of included studies. The initial search results were 163 articles (PubMed&#x02009;=&#x02009;32; Google Scholar&#x02009;=&#x02009;103; Embase&#x02009;=&#x02009;28). After a thorough screening, data from six articles were selected.</p></caption><graphic xlink:href="HSR2-8-e70495-g003" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="hsr270495-sec-0120"><label>2.4.2</label><title>Inclusion and Exclusion Criteria</title><p>The inclusion criteria for the studies were: (1) investigating the association between polymorphism at rs3758391 of <italic toggle="yes">SIRT1</italic> gene with T2DM; (2) it must be a case&#x02010;control study with genotype counts. The review articles, studies with animal models, and studies investigating the association between other SNPs of <italic toggle="yes">SIRT1</italic> and T2DM were excluded (Figure&#x000a0;<xref rid="hsr270495-fig-0002" ref-type="fig">2</xref>).</p></sec></sec><sec id="hsr270495-sec-0130"><label>2.5</label><title>Data Extraction Procedure</title><p>Two authors independently searched the databases to find the relevant articles and any discrepancy was resolved by discussion. The data included the relevant author's name, year, number of case and controls, followed by genotype data for the case and controls for each study (Table&#x000a0;<xref rid="hsr270495-tbl-0002" ref-type="table">2</xref>). The quality evaluation of the included studies for the meta&#x02010;analysis was assessed using the Newcastle&#x02010;Ottawa scale (Table&#x000a0;<xref rid="hsr270495-tbl-0003" ref-type="table">3</xref>).</p><table-wrap position="float" id="hsr270495-tbl-0002" content-type="Table"><label>Table 2</label><caption><p>Characterization of included studies.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" colspan="14" valign="bottom" rowspan="1">rs3758391</th></tr><tr style="border-bottom:solid 1px #000000" valign="bottom"><th rowspan="2" align="left" valign="bottom" colspan="1">Author</th><th rowspan="2" align="center" valign="bottom" colspan="1">Year</th><th colspan="2" align="center" valign="bottom" rowspan="1">Population</th><th colspan="2" align="center" valign="bottom" rowspan="1">Allele (Case)</th><th colspan="2" align="center" valign="bottom" rowspan="1">Allele (Control)</th><th colspan="3" align="center" valign="bottom" rowspan="1">Genotype (Case)</th><th colspan="3" align="center" valign="bottom" rowspan="1">Genotype (Control)</th></tr><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="center" valign="bottom" rowspan="1" colspan="1">Case</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control</th><th align="center" valign="bottom" rowspan="1" colspan="1">T allele</th><th align="center" valign="bottom" rowspan="1" colspan="1">C allele</th><th align="center" valign="bottom" rowspan="1" colspan="1">T allele</th><th align="center" valign="bottom" rowspan="1" colspan="1">C allele</th><th align="center" valign="bottom" rowspan="1" colspan="1">T/T</th><th align="center" valign="bottom" rowspan="1" colspan="1">T/C</th><th align="center" valign="bottom" rowspan="1" colspan="1">C/C</th><th align="center" valign="bottom" rowspan="1" colspan="1">T/T</th><th align="center" valign="bottom" rowspan="1" colspan="1">T/C</th><th align="center" valign="bottom" rowspan="1" colspan="1">C/C</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">M. Cruz</td><td align="center" valign="top" rowspan="1" colspan="1">2010</td><td align="center" valign="top" rowspan="1" colspan="1">520</td><td align="center" valign="top" rowspan="1" colspan="1">547</td><td align="center" valign="top" rowspan="1" colspan="1">668</td><td align="center" valign="top" rowspan="1" colspan="1">372</td><td align="center" valign="top" rowspan="1" colspan="1">638</td><td align="center" valign="top" rowspan="1" colspan="1">456</td><td align="center" valign="top" rowspan="1" colspan="1">215</td><td align="center" valign="top" rowspan="1" colspan="1">238</td><td align="center" valign="top" rowspan="1" colspan="1">67</td><td align="center" valign="top" rowspan="1" colspan="1">186</td><td align="center" valign="top" rowspan="1" colspan="1">266</td><td align="center" valign="top" rowspan="1" colspan="1">95</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ekta Rai</td><td align="center" valign="top" rowspan="1" colspan="1">2012</td><td align="center" valign="top" rowspan="1" colspan="1">692</td><td align="center" valign="top" rowspan="1" colspan="1">850</td><td align="center" valign="top" rowspan="1" colspan="1">686</td><td align="center" valign="top" rowspan="1" colspan="1">698</td><td align="center" valign="top" rowspan="1" colspan="1">866</td><td align="center" valign="top" rowspan="1" colspan="1">834</td><td align="center" valign="top" rowspan="1" colspan="1">173</td><td align="center" valign="top" rowspan="1" colspan="1">340</td><td align="center" valign="top" rowspan="1" colspan="1">179</td><td align="center" valign="top" rowspan="1" colspan="1">238</td><td align="center" valign="top" rowspan="1" colspan="1">390</td><td align="center" valign="top" rowspan="1" colspan="1">222</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Leena Kovanen</td><td align="center" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">300</td><td align="center" valign="top" rowspan="1" colspan="1">5133</td><td align="center" valign="top" rowspan="1" colspan="1">233</td><td align="center" valign="top" rowspan="1" colspan="1">365</td><td align="center" valign="top" rowspan="1" colspan="1">3992</td><td align="center" valign="top" rowspan="1" colspan="1">6252</td><td align="center" valign="top" rowspan="1" colspan="1">45</td><td align="center" valign="top" rowspan="1" colspan="1">143</td><td align="center" valign="top" rowspan="1" colspan="1">111</td><td align="center" valign="top" rowspan="1" colspan="1">785</td><td align="center" valign="top" rowspan="1" colspan="1">2422</td><td align="center" valign="top" rowspan="1" colspan="1">1915</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yi Peng</td><td align="center" valign="top" rowspan="1" colspan="1">2018</td><td align="center" valign="top" rowspan="1" colspan="1">148</td><td align="center" valign="top" rowspan="1" colspan="1">148</td><td align="center" valign="top" rowspan="1" colspan="1">250</td><td align="center" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">235</td><td align="center" valign="top" rowspan="1" colspan="1">61</td><td align="center" valign="top" rowspan="1" colspan="1">105</td><td align="center" valign="top" rowspan="1" colspan="1">40</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">93</td><td align="center" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ramin Tavakoli Faradonbeh</td><td align="center" valign="top" rowspan="1" colspan="1">2019</td><td align="center" valign="top" rowspan="1" colspan="1">132</td><td align="center" valign="top" rowspan="1" colspan="1">66</td><td align="center" valign="top" rowspan="1" colspan="1">121</td><td align="center" valign="top" rowspan="1" colspan="1">143</td><td align="center" valign="top" rowspan="1" colspan="1">27</td><td align="center" valign="top" rowspan="1" colspan="1">105</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">51</td><td align="center" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">45</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mohammad Bagher Sadeghi</td><td align="center" valign="top" rowspan="1" colspan="1">2021</td><td align="center" valign="top" rowspan="1" colspan="1">403</td><td align="center" valign="top" rowspan="1" colspan="1">410</td><td align="center" valign="top" rowspan="1" colspan="1">311</td><td align="center" valign="top" rowspan="1" colspan="1">495</td><td align="center" valign="top" rowspan="1" colspan="1">343</td><td align="center" valign="top" rowspan="1" colspan="1">477</td><td align="center" valign="top" rowspan="1" colspan="1">53</td><td align="center" valign="top" rowspan="1" colspan="1">205</td><td align="center" valign="top" rowspan="1" colspan="1">145</td><td align="center" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">251</td><td align="center" valign="top" rowspan="1" colspan="1">113</td></tr><tr><td colspan="2" align="left" valign="top" rowspan="1">
<bold>Total</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>2195</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>7154</bold>
</td><td colspan="10" align="center" valign="top" rowspan="1"/></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="hsr270495-tbl-0003" content-type="Table"><label>Table 3</label><caption><p>Quality assessment of the included articles using Newcastle&#x02013;Ottawa scale.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr valign="bottom"><th rowspan="2" align="left" valign="bottom" colspan="1">Author</th><th rowspan="2" align="center" valign="bottom" colspan="1">Year</th><th colspan="4" style="border-bottom:solid 1px #000000" align="center" valign="bottom" rowspan="1">Selection</th><th align="center" valign="bottom" rowspan="1" colspan="1">Comparability</th><th colspan="3" style="border-bottom:solid 1px #000000" align="center" valign="bottom" rowspan="1">Exposure</th><th rowspan="2" align="center" valign="bottom" colspan="1">Total</th></tr><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="center" valign="bottom" rowspan="1" colspan="1">1</th><th align="center" valign="bottom" rowspan="1" colspan="1">2</th><th align="center" valign="bottom" rowspan="1" colspan="1">3</th><th align="center" valign="bottom" rowspan="1" colspan="1">4</th><th align="center" valign="bottom" rowspan="1" colspan="1">5</th><th align="center" valign="bottom" rowspan="1" colspan="1">6</th><th align="center" valign="bottom" rowspan="1" colspan="1">7</th><th align="center" valign="bottom" rowspan="1" colspan="1">8</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">M. Cruz</td><td align="center" valign="top" rowspan="1" colspan="1">2010</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">*******</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ekta Rai</td><td align="center" valign="top" rowspan="1" colspan="1">2012</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">*****</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Leena Kovanen</td><td align="center" valign="top" rowspan="1" colspan="1">2015</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">*****</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yi Peng</td><td align="center" valign="top" rowspan="1" colspan="1">2018</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">******</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ramin Tavakoli Faradonbeh</td><td align="center" valign="top" rowspan="1" colspan="1">2019</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">******</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mohammad Bagher Sadeghi</td><td align="center" valign="top" rowspan="1" colspan="1">2021</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">******</td></tr></tbody></table><table-wrap-foot><fn id="hsr270495-tbl3-note-0001"><p>1&#x02009;=&#x02009;Adequate case definition</p></fn><fn id="hsr270495-tbl3-note-0002"><p>2&#x02009;=&#x02009;Representativeness of the cases</p></fn><fn id="hsr270495-tbl3-note-0003"><p>3&#x02009;=&#x02009;Selection of controls</p></fn><fn id="hsr270495-tbl3-note-0004"><p>4&#x02009;=&#x02009;Definition of controls</p></fn><fn id="hsr270495-tbl3-note-0005"><p>5&#x02009;=&#x02009;Comparability of cases and controls on the basis of the design or analysis</p></fn><fn id="hsr270495-tbl3-note-0006"><p>6&#x02009;=&#x02009;Ascertainment of exposure</p></fn><fn id="hsr270495-tbl3-note-0007"><p>7&#x02009;=&#x02009;Same method of ascertainment for cases and controls</p></fn><fn id="hsr270495-tbl3-note-0008"><p>8&#x02009;=&#x02009;Nonresponse rate</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="hsr270495-sec-0140"><label>2.6</label><title>Statistical Analysis</title><p>Two tailed tests were utilized for performing all the statistical tests. Normality distribution of data was checked using Q&#x02013;Q plots and Shapiro&#x02010;Wilk tests. For not normally distributed data we used Mann&#x02010;Whitney U test for all continuous variables while we used the chi&#x02010;square test to compare the categorical variables between two groups. Multivariate logistic regression analysis was used to calculate the odds ratio (OR) along with 95% confidence intervals (CIs) to compare the genotype and allele frequencies between the case and control group. <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered as statistically significant. The statistical analyses were performed using SPSS v27.</p><p>To conduct the meta&#x02010;analysis data was extracted from each case&#x02010;control study and organized in a 2&#x02009;&#x000d7;&#x02009;2 table. Classification criteria were diagnosis and type of alley they had. The pooled odds ratio (OR) with 95% CIs were calculated using the random effects model for all six genetic models to find the association of rs3758391 polymorphism with T2DM. Heterogeneity was calculated using Cochran's Q&#x02010;test and its magnitude was evaluated using I<sup>2</sup> test. As we found significant heterogeneity (more than 50%) so we used the random effect model instead of the fixed effect model. Publication bias was evaluated using Begg&#x02010;Mazumdar's rank correlation test [<xref rid="hsr270495-bib-0044" ref-type="bibr">44</xref>] and Egger's regression test [<xref rid="hsr270495-bib-0045" ref-type="bibr">45</xref>]. Funnel plots were used to adjust the odds ratio in case of significant publication bias. Trim and fill method was used to perform the sensitivity analysis. We could not perform moderator analysis for ethnicity as the number of studies were limited. All the <italic toggle="yes">p</italic>&#x02010;values reported were two tailed and <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant. Meta&#x02010;analysis was performed using Comprehensive meta&#x02010;analysis version 3 [<xref rid="hsr270495-bib-0046" ref-type="bibr">46</xref>].</p></sec></sec><sec sec-type="results" id="hsr270495-sec-0150"><label>3</label><title>Results</title><sec id="hsr270495-sec-0160"><label>3.1</label><title>Characteristics of the Study Population</title><p>The anthropometric and biochemical measurements of the study subjects are summarized in Table&#x000a0;<xref rid="hsr270495-tbl-0004" ref-type="table">4</xref>. 162 subjects were included in this study, of whom 72 were patients with T2DM and 90 were healthy control subjects. No significant difference was found in the age of the subjects, between the T2DM and control groups, (<italic toggle="yes">p</italic>&#x02009;=&#x02009;0.667). In case of the biochemical measurements, significant differences were found in HbA1c (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), FBG (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), PPG (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), HDL (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), and LDL (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001) between the T2DM patients and controls. However, no statistically significant difference was observed for SBP, DBP, TC, and TG between the cases and controls.</p><table-wrap position="float" id="hsr270495-tbl-0004" content-type="Table"><label>Table 4</label><caption><p>Anthropometric and clinical parameters of T2DM patients and healthy controls.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Parameters</th><th align="center" valign="bottom" rowspan="1" colspan="1">T2DM, median (IQR)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Controls, median (IQR)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="center" valign="top" rowspan="1" colspan="1">47.34 (39.25&#x02013;57.00)</td><td align="center" valign="top" rowspan="1" colspan="1">48.27 (37.73&#x02013;55.15)</td><td align="center" valign="top" rowspan="1" colspan="1">0.667</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender (male/female)</td><td align="center" valign="top" rowspan="1" colspan="1">25/47</td><td align="center" valign="top" rowspan="1" colspan="1">69/21</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">24.10 (22.45&#x02013;25.70)</td><td align="center" valign="top" rowspan="1" colspan="1">24.60 (22.18&#x02013;27.30)</td><td align="center" valign="top" rowspan="1" colspan="1">0.187</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SBP (mm Hg)</td><td align="center" valign="top" rowspan="1" colspan="1">125.00 (120.00&#x02013;130.00)</td><td align="center" valign="top" rowspan="1" colspan="1">121.50 (120.00&#x02013;130.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.352</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DBP mmHg</td><td align="center" valign="top" rowspan="1" colspan="1">80.00 (80.00&#x02013;90.00)</td><td align="center" valign="top" rowspan="1" colspan="1">78.50 (60.00&#x02013;80.00)</td><td align="center" valign="top" rowspan="1" colspan="1">0.054</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HbA1c (%)</td><td align="center" valign="top" rowspan="1" colspan="1">8.43 (7.23&#x02013;10.38)</td><td align="center" valign="top" rowspan="1" colspan="1">4.70 (4.10&#x02013;5.10)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x0003c;&#x02009;0.001</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FBG (mmol/L)</td><td align="center" valign="top" rowspan="1" colspan="1">10.60 (8.33&#x02013;14.00)</td><td align="center" valign="top" rowspan="1" colspan="1">4.90 (4.48&#x02013;5.20)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x0003c;&#x02009;0.001</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PPG (mmol/L)</td><td align="center" valign="top" rowspan="1" colspan="1">16.40 (12.53&#x02013;20.68)</td><td align="center" valign="top" rowspan="1" colspan="1">6.30 (5.90&#x02013;6.70)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x0003c;&#x02009;0.001</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TC (mg/dl)</td><td align="center" valign="top" rowspan="1" colspan="1">192.50 (162.00&#x02013;222.75)</td><td align="center" valign="top" rowspan="1" colspan="1">195.00 (159.75&#x02013;224.25)</td><td align="center" valign="top" rowspan="1" colspan="1">0.874</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HDL (mg/dl)</td><td align="center" valign="top" rowspan="1" colspan="1">41.50 (35.00&#x02013;52.00)</td><td align="center" valign="top" rowspan="1" colspan="1">62.00 (51.00&#x02013;74.50)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x0003c;&#x02009;0.001</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LDL (mg/dl)</td><td align="center" valign="top" rowspan="1" colspan="1">122.00 (85.25&#x02013;157.00)</td><td align="center" valign="top" rowspan="1" colspan="1">86.50 (65.50&#x02013;107.25)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>&#x0003c;&#x02009;0.001</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TG (mg/dl)</td><td align="center" valign="top" rowspan="1" colspan="1">168.50 (117.25&#x02013;218.75)</td><td align="center" valign="top" rowspan="1" colspan="1">186.50 (138.75&#x02013;268.25)</td><td align="center" valign="top" rowspan="1" colspan="1">0.516</td></tr></tbody></table><table-wrap-foot><fn id="hsr270495-tbl4-note-0001"><p>
<italic toggle="yes">Note:</italic> The Mann&#x02010;Whitney <italic toggle="yes">U</italic> test was used to compare the continuous variables between the T2DM and control groups. <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant. <italic toggle="yes">p&#x02009;</italic>&#x0003c;&#x02009;0.05 values are made bold.</p></fn><fn id="hsr270495-tbl4-note-0002"><p>Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; FBG, fasting blood glucose; HbA1c, glycated hemoglobin; HDL, high density lipoprotein; IQR, interquartile range; LDL, low density lipoprotein; PPG, postprandial blood glucose; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="hsr270495-sec-0170"><label>3.2</label><title>Genetic Association Analysis</title><p>The genotype and allele frequencies of rs3758391 polymorphism of the T2DM patients and healthy controls are shown in Table&#x000a0;<xref rid="hsr270495-tbl-0005" ref-type="table">5</xref>. We found that the codominant model (TT vs. CC; OR&#x02009;=&#x02009;3.88; 95% CI&#x02009;=&#x02009;1.34&#x02013;11.25; <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.012) and recessive model (TT vs. CC&#x02009;+&#x02009;CT; OR&#x02009;=&#x02009;2.83; 95% CI 1.12&#x02013;7.09; <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.027), showed a significant association between rs3758391 polymorphism and risk of T2DM. We also found that the T allele also conferred an increased risk to T2DM by 1.67&#x02010;folds (T vs. C; OR&#x02009;=&#x02009;1.67; 95% CI 1.07&#x02013;2.60; <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.024). However, no significant association was found between the anthropometric&#x02010;biochemical measurements and CT&#x02009;+&#x02009;TT versus CC genetic model in either T2DM or controls (Table&#x000a0;<xref rid="hsr270495-tbl-0006" ref-type="table">6</xref>).</p><table-wrap position="float" id="hsr270495-tbl-0005" content-type="Table"><label>Table 5</label><caption><p>Genotype and allelic frequencies of <italic toggle="yes">SIRT1</italic> rs3758391 polymorphism in T2DM patients and healthy controls.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Genotype</th><th align="center" valign="bottom" rowspan="1" colspan="1">T2DM, <italic toggle="yes">n</italic> (%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Control, <italic toggle="yes">n</italic> (%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">OR (95%CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Codominant</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TT</td><td align="center" valign="top" rowspan="1" colspan="1">7 (9.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">21 (23.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">3.88 (1.34&#x02013;11.25)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.012</bold>
<xref rid="hsr270495-tbl5-note-0003" ref-type="table-fn">*</xref>
</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CT</td><td align="center" valign="top" rowspan="1" colspan="1">43 (59.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">52 (57.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.57 (0.74&#x02013;3.32)</td><td align="center" valign="top" rowspan="1" colspan="1">0.242</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CC</td><td align="center" valign="top" rowspan="1" colspan="1">22 (30.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">17 (18.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Dominant</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CT&#x02009;+&#x02009;TT</td><td align="center" valign="top" rowspan="1" colspan="1">50 (69.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">73 (81.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.89 (0.91&#x02013;3.91)</td><td align="center" valign="top" rowspan="1" colspan="1">0.087</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CC</td><td align="center" valign="top" rowspan="1" colspan="1">22 (30.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">17 (18.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Recessive</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TT</td><td align="center" valign="top" rowspan="1" colspan="1">7 (9.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">21 (23.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.83 (1.12&#x02013;7.09)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.027</bold>
<xref rid="hsr270495-tbl5-note-0003" ref-type="table-fn">*</xref>
</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CC&#x02009;+&#x02009;CT</td><td align="center" valign="top" rowspan="1" colspan="1">65 (90.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">69 (76.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Overdominant</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CT</td><td align="center" valign="top" rowspan="1" colspan="1">43 (59.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">52 (57.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.92 (0.49&#x02013;1.73)</td><td align="center" valign="top" rowspan="1" colspan="1">0.803</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CC&#x02009;+&#x02009;TT</td><td align="center" valign="top" rowspan="1" colspan="1">29 (40.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">38 (42.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Alleles</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">T</td><td align="center" valign="top" rowspan="1" colspan="1">57 (39.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">94 (52.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.67 (1.07&#x02013;2.60)</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>0.024</bold>
<xref rid="hsr270495-tbl5-note-0003" ref-type="table-fn">*</xref>
</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">C</td><td align="center" valign="top" rowspan="1" colspan="1">87 (60.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">86 (47.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="hsr270495-tbl5-note-0001"><p>
<italic toggle="yes">Note:</italic> The Chi&#x02010;square test was used to analyze the genotypes and allele frequencies in the groups. Binary logistic regression were used to assess the association between the genotypes and T2DM. <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></fn><fn id="hsr270495-tbl5-note-0002"><p>Abbreviations: CI, confidence interval; OR, odds ratio; T2DM, type 2 diabetes mellitus.</p></fn><fn id="hsr270495-tbl5-note-0003"><label>*</label><p>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="hsr270495-tbl-0006" content-type="Table"><label>Table 6</label><caption><p>Association between <italic toggle="yes">SIRT1</italic> rs3758391 polymorphism and anthropometric and clinical characteristics of T2DM patients and healthy controls.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">rs3758391</th><th align="center" valign="bottom" rowspan="1" colspan="1">Genotype</th><th align="center" valign="bottom" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</th><th align="center" valign="bottom" rowspan="1" colspan="1">SBP (mm Hg)</th><th align="center" valign="bottom" rowspan="1" colspan="1">DBP mmHg</th><th align="center" valign="bottom" rowspan="1" colspan="1">HbA1c (%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">FBG (mmol/L)</th><th align="center" valign="bottom" rowspan="1" colspan="1">PPG (mmol/L)</th><th align="center" valign="bottom" rowspan="1" colspan="1">TC (mg/dl)</th><th align="center" valign="bottom" rowspan="1" colspan="1">HDL (mg/dl)</th><th align="center" valign="bottom" rowspan="1" colspan="1">LDL (mg/dl)</th><th align="center" valign="bottom" rowspan="1" colspan="1">TG (mg/dl)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">T2DM</td><td align="center" valign="top" rowspan="1" colspan="1">CT&#x02009;+&#x02009;TT</td><td align="center" valign="top" rowspan="1" colspan="1">24.15 (21.75&#x02013;25.75)</td><td align="center" valign="top" rowspan="1" colspan="1">125.00 (120.00&#x02013; 130.00)</td><td align="center" valign="top" rowspan="1" colspan="1">80.00 (80.00&#x02013; 85.00)</td><td align="center" valign="top" rowspan="1" colspan="1">8.65 (7.20&#x02013;0.33)</td><td align="center" valign="top" rowspan="1" colspan="1">10.45 (8.38&#x02013;3.88)</td><td align="center" valign="top" rowspan="1" colspan="1">16.90 (13.00&#x02013; 20.35)</td><td align="center" valign="top" rowspan="1" colspan="1">192.50 (164.25&#x02013;216.75)</td><td align="center" valign="top" rowspan="1" colspan="1">40.50 (35.00&#x02013; 52.00)</td><td align="center" valign="top" rowspan="1" colspan="1">122.00 (86.00&#x02013;157.00)</td><td align="center" valign="top" rowspan="1" colspan="1">175.50 (127.00&#x02013; 216.75)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">CC (ref)</td><td align="center" valign="top" rowspan="1" colspan="1">23.90 (22.63&#x02013; 25.60)</td><td align="center" valign="top" rowspan="1" colspan="1">130.00 (120.00&#x02013;130.00)</td><td align="center" valign="top" rowspan="1" colspan="1">80.00 (80.00&#x02013; 90.00)</td><td align="center" valign="top" rowspan="1" colspan="1">8.43 (7.30&#x02013; 10.63)</td><td align="center" valign="top" rowspan="1" colspan="1">10.80 (8.18&#x02013;14.25)</td><td align="center" valign="top" rowspan="1" colspan="1">15.95 (11.78&#x02013; 20.88)</td><td align="center" valign="top" rowspan="1" colspan="1">195.00 (147.00 &#x02013;223.50)</td><td align="center" valign="top" rowspan="1" colspan="1">42.50 (35.00&#x02013;52.00)</td><td align="center" valign="top" rowspan="1" colspan="1">106.00 (66.00&#x02013;158.50)</td><td align="center" valign="top" rowspan="1" colspan="1">148.50 (110.50&#x02013; 226.50)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value</td><td align="center" valign="top" rowspan="1" colspan="1">0.921</td><td align="center" valign="top" rowspan="1" colspan="1">0.680</td><td align="center" valign="top" rowspan="1" colspan="1">0.317</td><td align="center" valign="top" rowspan="1" colspan="1">0.798</td><td align="center" valign="top" rowspan="1" colspan="1">0.921</td><td align="center" valign="top" rowspan="1" colspan="1">0.798</td><td align="center" valign="top" rowspan="1" colspan="1">0.798</td><td align="center" valign="top" rowspan="1" colspan="1">0.798</td><td align="center" valign="top" rowspan="1" colspan="1">0.955</td><td align="center" valign="top" rowspan="1" colspan="1">0.443</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Control</td><td align="center" valign="top" rowspan="1" colspan="1">CT&#x02009;+&#x02009;TT</td><td align="center" valign="top" rowspan="1" colspan="1">24.60 (21.95&#x02013; 27.65)</td><td align="center" valign="top" rowspan="1" colspan="1">122.00 (120.00&#x02013; 130.00)</td><td align="center" valign="top" rowspan="1" colspan="1">80.00 (68.00&#x02013; 80.00)</td><td align="center" valign="top" rowspan="1" colspan="1">4.60 (4.15&#x02013; 5.00)</td><td align="center" valign="top" rowspan="1" colspan="1">4.90 (4.30&#x02013; 5.20)</td><td align="center" valign="top" rowspan="1" colspan="1">6.30 (5.85&#x02013; 6.70)</td><td align="center" valign="top" rowspan="1" colspan="1">200.00 (162.50&#x02013; 229.00)</td><td align="center" valign="top" rowspan="1" colspan="1">62.00 (51.00&#x02013; 76.50)</td><td align="center" valign="top" rowspan="1" colspan="1">88.00 (65.00&#x02013; 108.50)</td><td align="center" valign="top" rowspan="1" colspan="1">204.00 (145.00&#x02013; 272.00)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">CC (ref)</td><td align="center" valign="top" rowspan="1" colspan="1">24.60 (23.05&#x02013; 25.15)</td><td align="center" valign="top" rowspan="1" colspan="1">120.00 (110.00&#x02013; 130.00)</td><td align="center" valign="top" rowspan="1" colspan="1">70.00 (59.00&#x02013; 80.00)</td><td align="center" valign="top" rowspan="1" colspan="1">4.70 (3.85&#x02013;5.30)</td><td align="center" valign="top" rowspan="1" colspan="1">5.00 (4.80&#x02013; 5.40)</td><td align="center" valign="top" rowspan="1" colspan="1">6.35 (6.10&#x02013; 6.78)</td><td align="center" valign="top" rowspan="1" colspan="1">182.00 (144.50&#x02013; 219.17)</td><td align="center" valign="top" rowspan="1" colspan="1">63.00 (56.00&#x02013; 69.50)</td><td align="center" valign="top" rowspan="1" colspan="1">84.00 (60.50&#x02013; 100.00)</td><td align="center" valign="top" rowspan="1" colspan="1">158.93 (89.00&#x02013; 255.00)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value</td><td align="center" valign="top" rowspan="1" colspan="1">0.501</td><td align="center" valign="top" rowspan="1" colspan="1">0.590</td><td align="center" valign="top" rowspan="1" colspan="1">0.106</td><td align="center" valign="top" rowspan="1" colspan="1">0.942</td><td align="center" valign="top" rowspan="1" colspan="1">0.205</td><td align="center" valign="top" rowspan="1" colspan="1">0.821</td><td align="center" valign="top" rowspan="1" colspan="1">0.157</td><td align="center" valign="top" rowspan="1" colspan="1">0.919</td><td align="center" valign="top" rowspan="1" colspan="1">0.281</td><td align="center" valign="top" rowspan="1" colspan="1">0.590</td></tr></tbody></table><table-wrap-foot><fn id="hsr270495-tbl6-note-0001"><p>
<italic toggle="yes">Note:</italic> The Mann&#x02010;Whitney test was used to assess the association between the studied genotype and the anthropometric and clinical data. <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></fn><fn id="hsr270495-tbl6-note-0002"><p>Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; FBG, fasting blood glucose; HbA1c, glycated hemoglobin; HDL, high density lipoprotein; LDL, low density lipoprotein; PPG, postprandial blood glucose; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="hsr270495-sec-0180"><label>3.3</label><title>Meta&#x02010;Analysis Results</title><p>Our meta&#x02010;analysis revealed an increased odds ratio for T2DM in all six genetic models for this polymorphism although none of them were statistically significant (Table&#x000a0;<xref rid="hsr270495-tbl-0007" ref-type="table">7</xref>, Figures&#x000a0;<xref rid="hsr270495-fig-0003" ref-type="fig">3</xref>, <xref rid="hsr270495-fig-0004" ref-type="fig">4</xref>). The highest odds ratio was found in the codominant model 1 (TT vs. CC; OR&#x02009;=&#x02009;1.32, 95%CI&#x02009;=&#x02009;0.90&#x02013;1.95, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.158), while the <italic toggle="yes">p</italic>&#x02010;value was lowest for the allelic model (T vs. C; OR&#x02009;=&#x02009;1.20, 95% CI&#x02009;=&#x02009;0.96&#x02013;1.51, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.115). We found a higher percentage of heterogeneity in all six models which reveals the variability of data in the case&#x02010;control studies which were included in this meta&#x02010;analysis. We found no publication bias in both Egger's regression test and Begg&#x02010;Mazumdar's rank correlation tests.</p><table-wrap position="float" id="hsr270495-tbl-0007" content-type="Table"><label>Table 7</label><caption><p>Association of rs3758391 with type 2 diabetes.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr valign="bottom"><th rowspan="2" align="left" valign="bottom" colspan="1">Model name</th><th colspan="3" style="border-bottom:solid 1px #000000" align="center" valign="bottom" rowspan="1">Association test</th><th align="center" valign="bottom" rowspan="1" colspan="1"/><th colspan="3" style="border-bottom:solid 1px #000000" align="center" valign="bottom" rowspan="1">Heterogeneity test</th><th colspan="2" style="border-bottom:solid 1px #000000" align="center" valign="bottom" rowspan="1">Publication Bias (<italic toggle="yes">p</italic> value)</th></tr><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="center" valign="bottom" rowspan="1" colspan="1">Odds Ratio (OR)</th><th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value</th><th align="center" valign="bottom" rowspan="1" colspan="1">Model</th><th align="center" valign="bottom" rowspan="1" colspan="1">Q value</th><th align="center" valign="bottom" rowspan="1" colspan="1">I<sup>2</sup> value</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value</th><th align="center" valign="bottom" rowspan="1" colspan="1">Egger's test</th><th align="center" valign="bottom" rowspan="1" colspan="1">Begg&#x02010;Mazumdar's test</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Allelic (T vs. C)</td><td align="center" valign="top" rowspan="1" colspan="1">1.20</td><td align="center" valign="top" rowspan="1" colspan="1">0.96&#x02013;1.51</td><td align="center" valign="top" rowspan="1" colspan="1">0.115</td><td align="center" valign="top" rowspan="1" colspan="1">Rndom</td><td align="center" valign="top" rowspan="1" colspan="1">33.68</td><td align="center" valign="top" rowspan="1" colspan="1">85.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.00</td><td align="center" valign="top" rowspan="1" colspan="1">0.10</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dominant (CT&#x02009;+&#x02009;TT vs. CC)</td><td align="center" valign="top" rowspan="1" colspan="1">1.25</td><td align="center" valign="top" rowspan="1" colspan="1">0.87&#x02013;1.78</td><td align="center" valign="top" rowspan="1" colspan="1">0.232</td><td align="center" valign="top" rowspan="1" colspan="1">Random</td><td align="center" valign="top" rowspan="1" colspan="1">29.87</td><td align="center" valign="top" rowspan="1" colspan="1">83.26</td><td align="center" valign="top" rowspan="1" colspan="1">0.00</td><td align="center" valign="top" rowspan="1" colspan="1">0.22</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Recessive (TT vs. CC&#x02009;+&#x02009;CT)</td><td align="center" valign="top" rowspan="1" colspan="1">1.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.93&#x02013;1.58</td><td align="center" valign="top" rowspan="1" colspan="1">0.156</td><td align="center" valign="top" rowspan="1" colspan="1">Random</td><td align="center" valign="top" rowspan="1" colspan="1">15.73</td><td align="center" valign="top" rowspan="1" colspan="1">68.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.13</td><td align="center" valign="top" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Overdominant (CT vs. CC&#x02009;+&#x02009;TT)</td><td align="center" valign="top" rowspan="1" colspan="1">1.20</td><td align="center" valign="top" rowspan="1" colspan="1">0.77&#x02013;1.20</td><td align="center" valign="top" rowspan="1" colspan="1">0.710</td><td align="center" valign="top" rowspan="1" colspan="1">Random</td><td align="center" valign="top" rowspan="1" colspan="1">17.01</td><td align="center" valign="top" rowspan="1" colspan="1">70.60</td><td align="center" valign="top" rowspan="1" colspan="1">0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.88</td><td align="center" valign="top" rowspan="1" colspan="1">0.57</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Codominant 1 (TT vs. CC)</td><td align="center" valign="top" rowspan="1" colspan="1">1.32</td><td align="center" valign="top" rowspan="1" colspan="1">0.90&#x02013;1.95</td><td align="center" valign="top" rowspan="1" colspan="1">0.158</td><td align="center" valign="top" rowspan="1" colspan="1">Random</td><td align="center" valign="top" rowspan="1" colspan="1">19.80</td><td align="center" valign="top" rowspan="1" colspan="1">74.74</td><td align="center" valign="top" rowspan="1" colspan="1">0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.14</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Codominant 2(CT vs. CC)</td><td align="center" valign="top" rowspan="1" colspan="1">1.14</td><td align="center" valign="top" rowspan="1" colspan="1">0.83&#x02013;1.59</td><td align="center" valign="top" rowspan="1" colspan="1">0.421</td><td align="center" valign="top" rowspan="1" colspan="1">Random</td><td align="center" valign="top" rowspan="1" colspan="1">21.81</td><td align="center" valign="top" rowspan="1" colspan="1">77.07</td><td align="center" valign="top" rowspan="1" colspan="1">0.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.31</td><td align="center" valign="top" rowspan="1" colspan="1">0.35</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><fig position="float" fig-type="Figure" id="hsr270495-fig-0003"><label>Figure 3</label><caption><p>Forest plots of rs3758391 with T2DM risk in six genetic models. (A) Allelic model (T vs. C); (B) dominant model (CT&#x02009;+&#x02009;TT vs. CC); (C) recessive model (TT vs. CC&#x02009;+&#x02009;CT); (D) overdominant model (CT vs. CC&#x02009;+&#x02009;TT); (E) codominant 1 model (TT vs. CC) and (F) codominant 2 model (CT vs. CC).</p></caption><graphic xlink:href="HSR2-8-e70495-g002" position="anchor" id="jats-graphic-5"/></fig><fig position="float" fig-type="Figure" id="hsr270495-fig-0004"><label>Figure 4</label><caption><p>Funnel plots of rs3758391 with T2DM risk in six genetic models. (A) Allelic model (T vs. C); (B) dominant model (CT&#x02009;+&#x02009;TT vs. CC); (C) recessive model (TT vs. CC&#x02009;+&#x02009;CT); (D) overdominant model (CT vs. CC&#x02009;+&#x02009;TT); (E) codominant 1 model (TT vs. CC) and (F) codominant 2 model (CT vs. CC).</p></caption><graphic xlink:href="HSR2-8-e70495-g004" position="anchor" id="jats-graphic-7"/></fig></sec></sec><sec sec-type="discussion" id="hsr270495-sec-0190"><label>4</label><title>Discussion</title><p>This study aimed to investigate the association between <italic toggle="yes">SIRT1</italic> rs3758391 polymorphism and T2DM in Bangladeshi population. We found that the SNP rs3758391 T&#x02009;&#x0003e;&#x02009;C conferred an increased risk to T2DM. The TT genotype increases the risk of T2DM by 3.88 and 2.83 times under the codominant model and recessive model, respectively. In addition, the T allele increased the risk of T2DM by 1.67 times. In addition, analysis of the clinical and anthropometric parameters between the patients and healthy controls based on their genotype as carriers and noncarriers revealed no statistical significance. This implies that the risk alleles have no impact on the hypertension markers, diabetes markers and total lipid profile. Again, the meta&#x02010;analysis showed that rs3758391 increased the risk of T2DM in all six genetic models. However, they were not statistically significant, likely due to the variability in the data of the included studies. Some of the previous studies are also in agreement with our present findings. In the study by Cruz et al. in the Mexican population, the T allele of rs3758391 was found to be associated with a higher risk of T2DM [<xref rid="hsr270495-bib-0038" ref-type="bibr">38</xref>]. Fardonbeh et al. found that in Iranian population, the T allele of rs3758391 was also strongly associated with T2DM [<xref rid="hsr270495-bib-0037" ref-type="bibr">37</xref>]. However, Peng et al. [<xref rid="hsr270495-bib-0039" ref-type="bibr">39</xref>] and Kovanen et al. [<xref rid="hsr270495-bib-0041" ref-type="bibr">41</xref>] could not find any significant association between rs3758391 and T2DM susceptibility in Chinese and Finnish populations, whereas the Sadeghi et al. reported that rs3758391 variant conferred a protective role against T2DM in Iranian population [<xref rid="hsr270495-bib-0036" ref-type="bibr">36</xref>]. The differences in results may be partially explained by the differences in ethnicity, and the genetic variations may lead to differential expression level of SIRT1 protein in population of different ethnicities, thus serving as either a protective or risk factor.</p><p>SIRT1 regulates the activity of a variety of transcription factors, for example, forkhead&#x02010;box transcription factors (FOXOs), peroxisome proliferator&#x02010;activated receptor &#x003b3; (PPAR &#x003b3;) and nuclear factor&#x02010;&#x003ba;B (NF&#x02010;&#x003ba;B) [<xref rid="hsr270495-bib-0047" ref-type="bibr">47</xref>]. SIRT1, as a regulatory molecule impacts many vital biological processes such as glucose and lipid metabolism, inflammation, apoptosis, oxidative stress, cellular senescence and circadian rhythms [<xref rid="hsr270495-bib-0048" ref-type="bibr">48</xref>, <xref rid="hsr270495-bib-0049" ref-type="bibr">49</xref>]. Importantly, SIRT1 protects pancreatic &#x003b2;&#x02010;cells from dysfunctions induced by oxidative stress and inflammatory cytokines, likely through suppression of NF&#x02010;kB signaling [<xref rid="hsr270495-bib-0050" ref-type="bibr">50</xref>]. It activates insulin signaling in skeletal muscle cells [<xref rid="hsr270495-bib-0051" ref-type="bibr">51</xref>] and has the capacity to decrease inflammation in adipose tissue and monocytes, thereby leading to the alleviation of insulin resistance and T2DM [<xref rid="hsr270495-bib-0052" ref-type="bibr">52</xref>]. Therefore, changes in the expression and activity level of SIRT1 may lead to development of pathological conditions. SIRT1 levels have been found to decrease in diet&#x02010;induced obesity in rodents [<xref rid="hsr270495-bib-0053" ref-type="bibr">53</xref>, <xref rid="hsr270495-bib-0054" ref-type="bibr">54</xref>]. In humans, it has been reported that reduced expression levels of SIRT1 in circulating monocytes correlates with insulin resistance and metabolic syndrome [<xref rid="hsr270495-bib-0055" ref-type="bibr">55</xref>] and its levels also decrease in adipose tissue of obese subjects [<xref rid="hsr270495-bib-0056" ref-type="bibr">56</xref>]. Notably, reduced SIRT1 levels were found in patients with T2DM [<xref rid="hsr270495-bib-0039" ref-type="bibr">39</xref>, <xref rid="hsr270495-bib-0057" ref-type="bibr">57</xref>, <xref rid="hsr270495-bib-0058" ref-type="bibr">58</xref>].</p><p>Our meta&#x02010;analysis revealed no statistically significant association of the rs3758391 polymorphism at <italic toggle="yes">SIRT1</italic> gene with T2DM. As far as we are aware, this is the first meta&#x02010;analysis done between rs3758391 single&#x02010;nucleotide polymorphism and T2DM. It is also worth noting that, the number of studies included for our meta&#x02010;analysis was comparatively small. Moreover, the included studies consisted of population from different ethnicities, which have resulted in significant heterogeneity. Although, we tried to counter that using the random effects model, but the results of our meta&#x02010;analysis cannot be generalized for people of all ethnicities. This may be a reason for difference in the outcome of our case&#x02010;control study with the meta&#x02010;analysis. Furthermore, moderator analysis based on ethnicity could not be performed due to the unavailability of studies with similar ethnic backgrounds. As a result, we see the discrepancies that must be further investigated by conducting more case&#x02010;control studies between this SNP and T2DM in larger sample size and similar ethnic backgrounds to see if there is ethnic difference and whether this SNP confers risk or protective effect to T2DM in Bangladeshi population.</p><p>Despite the work we carried out, our study has some limitations, which needs to be acknowledged. Our sample size was relatively small which may not be sufficient to give a very robust genotype&#x02010;disease interaction. In addition, previous studies have found decreased levels of SIRT1 in T2DM patients. However, we could not check the gene or protein expression levels in our study subjects, which would otherwise demonstrate the effect of the SNP on the gene expression levels. These limitations should be addressed in future studies. As T2DM is increasing at an alarming rate in Bangladesh, the development of effective, yet affordable means are required to assess the risk of development of T2DM based on genetic variants in our population. Future studies that include other SNPs and genes with larger sample sizes will be performed to help establish a T2DM biobank for the Bangladeshi population. This in turn, can assist clinicians in prevention, early detection and proper management of T2DM, helping to decrease the burden of healthcare costs for our developing country.</p></sec><sec sec-type="conclusions" id="hsr270495-sec-0200"><label>5</label><title>Conclusion</title><p>Our current study shows that rs3758391 is associated with T2DM susceptibility. However, future replication studies in diverse ethnic groups with larger sample sizes should be performed to obtain a more robust and comprehensive association result.</p></sec><sec id="hsr270495-sec-0210"><title>Author Contributions</title><p>
<bold>Rezwana Ahmed:</bold> conceptualization, data curation, formal analysis, funding acquisition, methodology, visualization, writing&#x02013;original draft. <bold>Mushfikur Rahman Safa:</bold> investigation, data curation. <bold>Zahidul Islam Zahid:</bold> investigation, project administration. <bold>Md. Mazharul Islam Chowdhury:</bold> software, investigation. <bold>A.B.M. Kamrul Hasan:</bold> resources, writing&#x02013;review and editing, supervision. <bold>Md Shaki Mostaid:</bold> conceptualization, formal analysis, methodology, software, validation, visualization, writing&#x02013;review and editing. <bold>Hasan Mahmud Reza:</bold> conceptualization, methodology, supervision, validation, visualization.</p></sec><sec sec-type="COI-statement" id="hsr270495-sec-0230"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="hsr270495-sec-0260"><title>Transparency Statement</title><p>The lead author Rezwana Ahmed, Hasan Mahmud Reza affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.</p></sec></body><back><ack id="hsr270495-sec-0220"><title>Acknowledgments</title><p>The authors are grateful to Dr. Farhana and Dr. Sadia Ahmed, for their assistance in data collection. This work was financially supported by a research grant (CTRGC&#x02010;20/SHLS/31) from North South University.</p></ack><sec sec-type="data-availability" id="hsr270495-sec-0250"><title>Data Availability Statement</title><p>All authors have read and approved the final version of the manuscript. Corresponding author had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis. The authors confirm that the data supporting the findings of this study are available within the article.</p><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list content-type="cited-references" id="hsr270495-bibl-0001"><title>References</title><ref id="hsr270495-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="hsr270495-cit-0001">
<string-name>
<given-names>K. L.</given-names>
<surname>Ong</surname>
</string-name>, <string-name>
<given-names>L. K.</given-names>
<surname>Stafford</surname>
</string-name>, <string-name>
<given-names>S. A.</given-names>
<surname>McLaughlin</surname>
</string-name>, et al., &#x0201c;<article-title>Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021</article-title>,&#x0201d; <source>Lancet</source>
<volume>402</volume>, no. <issue>10397</issue> (<year>2023</year>): <fpage>203</fpage>&#x02013;<lpage>234</lpage>.<pub-id pub-id-type="pmid">37356446</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="hsr270495-cit-0002">
<string-name>
<given-names>M.</given-names>
<surname>Roden</surname>
</string-name> and <string-name>
<given-names>G. I.</given-names>
<surname>Shulman</surname>
</string-name>, &#x0201c;<article-title>The Integrative Biology of Type 2 Diabetes</article-title>,&#x0201d; <source>Nature</source>
<volume>576</volume>, no. <issue>7785</issue> (<year>2019</year>): <fpage>51</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">31802013</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="hsr270495-cit-0003">
<string-name>
<given-names>S. S.</given-names>
<surname>Schwartz</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Epstein</surname>
</string-name>, <string-name>
<given-names>B. E.</given-names>
<surname>Corkey</surname>
</string-name>, <string-name>
<given-names>S. F. A.</given-names>
<surname>Grant</surname>
</string-name>, <string-name>
<given-names>J. R.</given-names>
<surname>Gavin</surname>
</string-name>, and <string-name>
<given-names>R. B.</given-names>
<surname>Aguilar</surname>
</string-name>, &#x0201c;<article-title>The Time is Right for a New Classification System for Diabetes: Rationale and Implications of the &#x003b2;&#x02010;cell&#x02010;centric Classification Schema</article-title>,&#x0201d; <source>Diabetes Care</source>
<volume>39</volume>, no. <issue>2</issue> (<year>2016</year>): <fpage>179</fpage>&#x02013;<lpage>186</lpage>.<pub-id pub-id-type="pmid">26798148</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="hsr270495-cit-0004">
<string-name>
<given-names>U.</given-names>
<surname>Galicia&#x02010;Garcia</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Benito&#x02010;Vicente</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Jebari</surname>
</string-name>, et al., &#x0201c;<article-title>Pathophysiology of Type 2 Diabetes Mellitus</article-title>,&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>21</volume>, no. <issue>17</issue> (<year>2020</year>): <fpage>6275</fpage>.<pub-id pub-id-type="pmid">32872570</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="hsr270495-cit-0005">
<string-name>
<given-names>B.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Hajifathalian</surname>
</string-name>, et al.,&#x0201c;<article-title>Worldwide Trends in Diabetes Since 1980: A Pooled Analysis of 751 Population&#x02010;Based Studies With 4.4 Million Participants</article-title>,&#x0201d; <source>Lancet</source>
<volume>387</volume>, no. <issue>10027</issue> (<year>2016</year>): <fpage>1513</fpage>&#x02013;<lpage>1530</lpage>.<pub-id pub-id-type="pmid">27061677</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="hsr270495-cit-0006">
<string-name>
<given-names>S.</given-names>
<surname>Chatterjee</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Khunti</surname>
</string-name>, and <string-name>
<given-names>M. J.</given-names>
<surname>Davies</surname>
</string-name>, &#x0201c;<article-title>Type 2 Diabetes</article-title>,&#x0201d; <source>Lancet</source>
<volume>389</volume>, no. <issue>10085</issue> (<year>2017</year>): <fpage>2239</fpage>&#x02013;<lpage>2251</lpage>.<pub-id pub-id-type="pmid">28190580</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="hsr270495-cit-0007">
<string-name>
<given-names>C.</given-names>
<surname>Fuchsberger</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Flannick</surname>
</string-name>, <string-name>
<given-names>T. M.</given-names>
<surname>Teslovich</surname>
</string-name>, et al., &#x0201c;<article-title>The Genetic Architecture of Type 2 Diabetes</article-title>,&#x0201d; <source>Nature</source>
<volume>536</volume>, no. <issue>7614</issue> (<year>2016</year>): <fpage>41</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="pmid">27398621</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="hsr270495-cit-0008">
<string-name>
<given-names>M. I.</given-names>
<surname>McCarthy</surname>
</string-name>, &#x0201c;<article-title>Genomics, Type 2 Diabetes, and Obesity</article-title>,&#x0201d; <source>New England Journal of Medicine</source>
<volume>363</volume>, no. <issue>24</issue> (<year>2010</year>): <fpage>2339</fpage>&#x02013;<lpage>2350</lpage>.<pub-id pub-id-type="pmid">21142536</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="hsr270495-cit-0009">
<string-name>
<given-names>G.</given-names>
<surname>Donmez</surname>
</string-name> and <string-name>
<given-names>L.</given-names>
<surname>Guarente</surname>
</string-name>, &#x0201c;<article-title>Aging and Disease: Connections to Sirtuins</article-title>,&#x0201d; <source>Aging Cell</source>
<volume>9</volume>, no. <issue>2</issue> (<year>2010</year>): <fpage>285</fpage>&#x02013;<lpage>290</lpage>.<pub-id pub-id-type="pmid">20409078</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="hsr270495-cit-0010">
<string-name>
<given-names>M. C.</given-names>
<surname>Haigis</surname>
</string-name> and <string-name>
<given-names>D. A.</given-names>
<surname>Sinclair</surname>
</string-name>, &#x0201c;<article-title>Mammalian Sirtuins: Biological Insights and Disease Relevance</article-title>,&#x0201d; <source>Annual Review of Pathology: Mechanisms of Disease</source>
<volume>5</volume>, no. <issue>1</issue> (<year>2010</year>): <fpage>253</fpage>&#x02013;<lpage>295</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="hsr270495-cit-0011">
<string-name>
<given-names>X.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Blander</surname>
</string-name>, <string-name>
<given-names>J. G.</given-names>
<surname>Tse</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Krieger</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Guarente</surname>
</string-name>, &#x0201c;<article-title>SIRT1 Deacetylates and Positively Regulates the Nuclear Receptor LXR</article-title>,&#x0201d; <source>Molecular Cell</source>
<volume>28</volume>, no. <issue>1</issue> (<year>2007</year>): <fpage>91</fpage>&#x02013;<lpage>106</lpage>.<pub-id pub-id-type="pmid">17936707</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="hsr270495-cit-0012">
<string-name>
<given-names>J. T.</given-names>
<surname>Rodgers</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Lerin</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Haas</surname>
</string-name>, <string-name>
<given-names>S. P.</given-names>
<surname>Gygi</surname>
</string-name>, <string-name>
<given-names>B. M.</given-names>
<surname>Spiegelman</surname>
</string-name>, and <string-name>
<given-names>P.</given-names>
<surname>Puigserver</surname>
</string-name>, &#x0201c;<article-title>Nutrient Control of Glucose Homeostasis Through a Complex of PGC&#x02010;1&#x003b1; and SIRT1</article-title>,&#x0201d; <source>Nature</source>
<volume>434</volume>, no. <issue>7029</issue> (<year>2005</year>): <fpage>113</fpage>&#x02013;<lpage>118</lpage>.<pub-id pub-id-type="pmid">15744310</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="hsr270495-cit-0013">
<string-name>
<given-names>M. C.</given-names>
<surname>Motta</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Divecha</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Lemieux</surname>
</string-name>, et al., &#x0201c;<article-title>Mammalian SIRT1 Represses Forkhead Transcription Factors</article-title>,&#x0201d; <source>Cell</source>
<volume>116</volume>, no. <issue>4</issue> (<year>2004</year>): <fpage>551</fpage>&#x02013;<lpage>563</lpage>.<pub-id pub-id-type="pmid">14980222</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="hsr270495-cit-0014">
<string-name>
<given-names>A.</given-names>
<surname>Brunet</surname>
</string-name>, <string-name>
<given-names>L. B.</given-names>
<surname>Sweeney</surname>
</string-name>, <string-name>
<given-names>J. F.</given-names>
<surname>Sturgill</surname>
</string-name>, et al., &#x0201c;<article-title>Stress&#x02010;Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase</article-title>,&#x0201d; <source>Science</source>
<volume>303</volume>, no. <issue>5666</issue> (<year>2004</year>): <fpage>2011</fpage>&#x02013;<lpage>2015</lpage>.<pub-id pub-id-type="pmid">14976264</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="hsr270495-cit-0015">
<string-name>
<given-names>T.</given-names>
<surname>Nakagawa</surname>
</string-name> and <string-name>
<given-names>L.</given-names>
<surname>Guarente</surname>
</string-name>, &#x0201c;<article-title>Sirtuins at a Glance</article-title>,&#x0201d; <source>Journal of Cell Science</source>
<volume>124</volume>, no. <issue>6</issue> (<year>2011</year>): <fpage>833</fpage>&#x02013;<lpage>838</lpage>.<pub-id pub-id-type="pmid">21378304</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="hsr270495-cit-0016">
<string-name>
<given-names>F.</given-names>
<surname>Yeung</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Hoberg</surname>
</string-name>, <string-name>
<given-names>C. S.</given-names>
<surname>Ramsey</surname>
</string-name>, et al., &#x0201c;<article-title>Modulation of NF&#x02010;&#x003ba;B&#x02010;Dependent Transcription and Cell Survival by the SIRT1 Deacetylase</article-title>,&#x0201d; <source>EMBO Journal</source>
<volume>23</volume>, no. <issue>12</issue> (<year>2004</year>): <fpage>2369</fpage>&#x02013;<lpage>2380</lpage>.<pub-id pub-id-type="pmid">15152190</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="hsr270495-cit-0017">
<string-name>
<given-names>A. S.</given-names>
<surname>Banks</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Kon</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Knight</surname>
</string-name>, et al., &#x0201c;<article-title>SirT1 Gain of Function Increases Energy Efficiency and Prevents Diabetes in Mice</article-title>,&#x0201d; <source>Cell Metabolism</source>
<volume>8</volume>, no. <issue>4</issue> (<year>2008</year>): <fpage>333</fpage>&#x02013;<lpage>341</lpage>.<pub-id pub-id-type="pmid">18840364</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="hsr270495-cit-0018">
<string-name>
<given-names>T.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Fu</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Pestell</surname>
</string-name>, and <string-name>
<given-names>A. A.</given-names>
<surname>Sauve</surname>
</string-name>, &#x0201c;<article-title>SIRT1 and Endocrine Signaling</article-title>,&#x0201d; <source>Trends in Endocrinology &#x00026; Metabolism</source>
<volume>17</volume>, no. <issue>5</issue> (<year>2006</year>): <fpage>186</fpage>&#x02013;<lpage>191</lpage>.<pub-id pub-id-type="pmid">16684606</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="hsr270495-cit-0019">
<string-name>
<given-names>H. Y.</given-names>
<surname>Cohen</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Miller</surname>
</string-name>, <string-name>
<given-names>K. J.</given-names>
<surname>Bitterman</surname>
</string-name>, et al., &#x0201c;<article-title>Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase</article-title>,&#x0201d; <source>Science</source>
<volume>305</volume>, no. <issue>5682</issue> (<year>2004</year>): <fpage>390</fpage>&#x02013;<lpage>392</lpage>.<pub-id pub-id-type="pmid">15205477</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="hsr270495-cit-0020">
<string-name>
<given-names>D.</given-names>
<surname>Herranz</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Mu&#x000f1;oz&#x02010;Martin</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Ca&#x000f1;amero</surname>
</string-name>, et al., &#x0201c;<article-title>Sirt1 Improves Healthy Ageing and Protects From Metabolic Syndrome&#x02010;Associated Cancer</article-title>,&#x0201d; <source>Nature Communications</source>
<volume>1</volume>, no. <issue>1</issue> (<year>2010</year>): <fpage>3</fpage>.</mixed-citation></ref><ref id="hsr270495-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="hsr270495-cit-0021">
<string-name>
<given-names>Y.</given-names>
<surname>Cao</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Jiang</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Xue</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, &#x0201c;<article-title>SIRT1 and Insulin Resistance</article-title>,&#x0201d; <source>Journal of Diabetes and Its Complications</source>
<volume>30</volume>, no. <issue>1</issue> (<year>2016</year>): <fpage>178</fpage>&#x02013;<lpage>183</lpage>.<pub-id pub-id-type="pmid">26422395</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="hsr270495-cit-0022">
<string-name>
<given-names>L.</given-names>
<surname>Bordone</surname>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Motta</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Picard</surname>
</string-name>, et al, &#x0201c;<article-title>Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic &#x003b2; Cells</article-title>,&#x0201d; <source>PLoS Biology</source>
<volume>4</volume>, no. <issue>2</issue> (<year>2006</year>): <fpage>210</fpage>&#x02013;<lpage>220</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="hsr270495-cit-0023">
<string-name>
<given-names>K. A.</given-names>
<surname>Moynihan</surname>
</string-name>, <string-name>
<given-names>A. A.</given-names>
<surname>Grimm</surname>
</string-name>, <string-name>
<given-names>M. M.</given-names>
<surname>Plueger</surname>
</string-name>, et al., &#x0201c;<article-title>Increased Dosage of Mammalian Sir2 in Pancreatic &#x003b2; Cells Enhances Glucose&#x02010;Stimulated Insulin Secretion in Mice</article-title>,&#x0201d; <source>Cell Metabolism</source>
<volume>2</volume>, no. <issue>2</issue> (<year>2005</year>): <fpage>105</fpage>&#x02013;<lpage>117</lpage>.<pub-id pub-id-type="pmid">16098828</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="hsr270495-cit-0024">
<string-name>
<given-names>F.</given-names>
<surname>Liang</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Kume</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Koya</surname>
</string-name>, &#x0201c;<article-title>SIRT1 and Insulin Resistance</article-title>,&#x0201d; <source>Nature Reviews Endocrinology</source>
<volume>5</volume>, no. <issue>7</issue> (<year>2009</year>): <fpage>367</fpage>&#x02013;<lpage>373</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="hsr270495-cit-0025">
<string-name>
<given-names>Y.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Giles</surname>
</string-name>, et al., &#x0201c;<article-title>Hepatic Overexpression of SIRT1 in Mice Attenuates Endoplasmic Reticulum Stress and Insulin Resistance in the Liver</article-title>,&#x0201d; <source>FASEB Journal</source>
<volume>25</volume>, no. <issue>5</issue> (<year>2011</year>): <fpage>1664</fpage>&#x02013;<lpage>1679</lpage>.<pub-id pub-id-type="pmid">21321189</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="hsr270495-cit-0026">
<string-name>
<given-names>J. N.</given-names>
<surname>Feige</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Lagouge</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Canto</surname>
</string-name>, et al., &#x0201c;<article-title>Specific SIRT1 Activation Mimics Low Energy Levels and Protects Against Diet&#x02010;Induced Metabolic Disorders by Enhancing Fat Oxidation</article-title>,&#x0201d; <source>Cell Metabolism</source>
<volume>8</volume>, no. <issue>5</issue> (<year>2008</year>): <fpage>347</fpage>&#x02013;<lpage>358</lpage>.<pub-id pub-id-type="pmid">19046567</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="hsr270495-cit-0027">
<string-name>
<given-names>M.</given-names>
<surname>Lagouge</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Argmann</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Gerhart&#x02010;Hines</surname>
</string-name>, et al., &#x0201c;<article-title>Resveratrol Improves Mitochondrial Function and Protects Against Metabolic Disease by Activating SIRT1 and PGC&#x02010;1&#x003b1;</article-title>,&#x0201d; <source>Cell</source>
<volume>127</volume>, no. <issue>6</issue> (<year>2006</year>): <fpage>1109</fpage>&#x02013;<lpage>1122</lpage>.<pub-id pub-id-type="pmid">17112576</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="hsr270495-cit-0028">
<string-name>
<given-names>S. M.</given-names>
<surname>Rizk</surname>
</string-name>, <string-name>
<given-names>S. A.</given-names>
<surname>El&#x02010;Maraghy</surname>
</string-name>, and <string-name>
<given-names>N. N.</given-names>
<surname>Nassar</surname>
</string-name>, &#x0201c;<article-title>A Novel Role for SIRT&#x02010;1 in L&#x02010;Arginine Protection Against STZ Induced Myocardial Fibrosis in Rats</article-title>,&#x0201d; <source>PLoS One</source>
<volume>9</volume>, no. <issue>12</issue> (<year>2014</year>): <elocation-id>e114560</elocation-id>.<pub-id pub-id-type="pmid">25501750</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="hsr270495-cit-0029">
<string-name>
<given-names>Z. Z.</given-names>
<surname>Chong</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>Y. C.</given-names>
<surname>Shang</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Maiese</surname>
</string-name>, &#x0201c;<article-title>Targeting Cardiovascular Disease With Novel SIRT1 Pathways</article-title>,&#x0201d; <source>Future Cardiology</source>
<volume>8</volume>, no. <issue>1</issue> (<year>2012</year>): <fpage>89</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">22185448</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="hsr270495-cit-0030">
<string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Liu</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Zhang</surname>
</string-name>, &#x0201c;<article-title>Sirtuins in Osteoarthritis: Current Understanding</article-title>,&#x0201d; <source>Frontiers in Immunology</source>
<volume>14</volume>, no. <issue>April</issue> (<year>2023</year>): <fpage>1</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="hsr270495-cit-0031">
<string-name>
<given-names>D. I.</given-names>
<surname>Razick</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Akhtar</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Wen</surname>
</string-name>, et al., &#x0201c;<article-title>The Role of Sirtuin 1 (SIRT1) in Neurodegeneration</article-title>,&#x0201d; <source>Cureus</source>
<volume>1</volume>, no. <issue>6</issue> (<year>2023</year>): <fpage>1</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="hsr270495-cit-0032">
<string-name>
<given-names>Y.</given-names>
<surname>Zhong</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Lee</surname>
</string-name>, and <string-name>
<given-names>J. C.</given-names>
<surname>He</surname>
</string-name>, &#x0201c;<article-title>SIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease</article-title>,&#x0201d; <source>Frontiers in Endocrinology</source>
<volume>9</volume> (<year>2018</year>), <pub-id pub-id-type="doi">10.3389/fendo.2018.00624</pub-id>.</mixed-citation></ref><ref id="hsr270495-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="hsr270495-cit-0033">
<string-name>
<given-names>A.</given-names>
<surname>Mihanfar</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Akbarzadeh</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Ghazizadeh Darband</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sadighparvar</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Majidinia</surname>
</string-name>, &#x0201c;<article-title>SIRT1: A Promising Therapeutic Target in Type 2 Diabetes Mellitus</article-title>,&#x0201d; <source>Archives of Physiology and Biochemistry</source>
<volume>130</volume>, no. <issue>1</issue> (<year>2024</year>): <fpage>13</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">34379994</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="hsr270495-cit-0034">
<string-name>
<given-names>J.</given-names>
<surname>Strycharz</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Rygielska</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Swiderska</surname>
</string-name>, et al., &#x0201c;<article-title>SIRT1 as a Therapeutic Target in Diabetic Complications</article-title>,&#x0201d; <source>Current Medicinal Chemistry</source>
<volume>25</volume>, no. <issue>9</issue> (<year>2018</year>): <fpage>1002</fpage>&#x02013;<lpage>1035</lpage>.<pub-id pub-id-type="pmid">29110598</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="hsr270495-cit-0035">
<string-name>
<given-names>J.</given-names>
<surname>Han</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Wei</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Wang</surname>
</string-name>, et al., &#x0201c;<article-title>Association of Genetic Variants of SIRT1 With Type 2 Diabetes Mellitus</article-title>,&#x0201d; <source>Gene Expression</source>
<volume>16</volume>, no. <issue>4</issue> (<year>2015</year>): <fpage>177</fpage>&#x02013;<lpage>185</lpage>.<pub-id pub-id-type="pmid">26637398</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="hsr270495-cit-0036">
<string-name>
<given-names>M. B.</given-names>
<surname>Sadeghi</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Nakhaee</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Saravani</surname>
</string-name>, <string-name>
<given-names>M. H.</given-names>
<surname>Sadeghi</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sargazi</surname>
</string-name>, and <string-name>
<given-names>M. H.</given-names>
<surname>Nia</surname>
</string-name>, &#x0201c;<article-title>SIRT1 Functional Polymorphisms (rs12778366, rs3758391) as Genetic Biomarkers of Susceptibility to Type 2 Diabetes Mellitus in Iranians: A Case&#x02010;Control Study and Computational Analysis</article-title>,&#x0201d; <source>International Journal of Diabetes in Developing Countries</source>
<volume>41</volume>, no. <issue>3</issue> (<year>2021</year>): <fpage>447</fpage>&#x02013;<lpage>455</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="hsr270495-cit-0037">
<string-name>
<given-names>R.</given-names>
<surname>Tavakoli Faradonbeh</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Zakerkish</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Karimi Akhormeh</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Mohammadtaghvaei</surname>
</string-name>, <string-name>
<given-names>M. T.</given-names>
<surname>Jalali</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Yaghooti</surname>
</string-name>, &#x0201c;<article-title>Association of the rs3758391 Polymorphism in the SIRT1 Gene With Diabetic Nephropathy and Decreased Estimated Glomerular Filtration Rate (GFR) in a Population From Southwest Iran</article-title>,&#x0201d; <source>International Journal of Diabetes in Developing Countries</source>
<volume>40</volume>, no. <issue>1</issue> (<year>2020</year>): <fpage>99</fpage>&#x02013;<lpage>105</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="hsr270495-cit-0038">
<string-name>
<given-names>M.</given-names>
<surname>Cruz</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Valladares&#x02010;Salgado</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Garcia&#x02010;Mena</surname>
</string-name>, et al., &#x0201c;<article-title>Candidate Gene Association Study Conditioning on Individual Ancestry in Patients With Type 2 Diabetes and Metabolic Syndrome From Mexico City</article-title>,&#x0201d; <source>Diabetes/Metabolism Research and Reviews</source>
<volume>26</volume>, no. <issue>4</issue> (<year>2010</year>): <fpage>261</fpage>&#x02013;<lpage>270</lpage>.<pub-id pub-id-type="pmid">20503258</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="hsr270495-cit-0039">
<string-name>
<given-names>Y.</given-names>
<surname>Peng</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Tang</surname>
</string-name>, et al., &#x0201c;<article-title>Influence of SIRT1 Polymorphisms for Diabetic Foot Susceptibility and Severity</article-title>,&#x0201d; <source>Medicine</source>
<volume>97</volume>, no. <issue>28</issue> (<year>2018</year>): <elocation-id>e11455</elocation-id>.<pub-id pub-id-type="pmid">29995800</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="hsr270495-cit-0040">
<string-name>
<given-names>E.</given-names>
<surname>Rai</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sharma</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Kaul</surname>
</string-name>, et al., &#x0201c;<article-title>The Interactive Effect of SIRT1 Promoter Region Polymorphism on Type 2 Diabetes Susceptibility in the North Indian Population</article-title>,&#x0201d; <source>PLoS One</source>
<volume>7</volume>, no. <issue>11</issue> (<year>2012</year>): <elocation-id>e48621</elocation-id>.<pub-id pub-id-type="pmid">23133645</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="hsr270495-cit-0041">
<string-name>
<given-names>L.</given-names>
<surname>Kovanen</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Donner</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Partonen</surname>
</string-name>, &#x0201c;<article-title>SIRT1 Polymorphisms Associate With Seasonal Weight Variation, Depressive Disorders, and Diastolic Blood Pressure in the General Population</article-title>,&#x0201d; <source>PLoS One</source>
<volume>10</volume>, no. <issue>10</issue> (<year>2015</year>): <elocation-id>e0141001</elocation-id>.<pub-id pub-id-type="pmid">26509718</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="hsr270495-cit-0042">
<string-name>
<given-names>F.</given-names>
<surname>Faul</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Erdfelder</surname>
</string-name>, <string-name>
<given-names>A. G.</given-names>
<surname>Lang</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Buchner</surname>
</string-name>, &#x0201c;<article-title>G*Power 3: A Flexible Statistical Power Analysis Program for the Social, Behavioral, and Biomedical Sciences</article-title>,&#x0201d; <source>Behavior Research Methods</source>
<volume>39</volume>, no. <issue>2</issue> (<year>2007</year>): <fpage>175</fpage>&#x02013;<lpage>191</lpage>.<pub-id pub-id-type="pmid">17695343</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="hsr270495-cit-0043">
<string-name>
<given-names>D.</given-names>
<surname>Moher</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Shamseer</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Clarke</surname>
</string-name>, et al., &#x0201c;<article-title>Preferred Reporting Items for Systematic Review and Meta&#x02010;Analysis Protocols (PRISMA&#x02010;P) 2015 Statement</article-title>,&#x0201d; <source>Systematic Reviews</source>
<volume>4</volume>, no. <issue>2</issue> (<year>2015</year>): <fpage>1</fpage>.<pub-id pub-id-type="pmid">25554246</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="hsr270495-cit-0044">
<string-name>
<given-names>C. B.</given-names>
<surname>Begg</surname>
</string-name> and <string-name>
<given-names>M.</given-names>
<surname>Mazumdar</surname>
</string-name>, &#x0201c;<article-title>Operating Characteristics of a Rank Correlation Test for Publication Bias</article-title>,&#x0201d; <source>Biometrics</source>
<volume>50</volume>, no. <issue>4</issue> (<year>1994</year>): <fpage>1088</fpage>&#x02013;<lpage>1101</lpage>.<pub-id pub-id-type="pmid">7786990</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="hsr270495-cit-0045">
<string-name>
<given-names>M.</given-names>
<surname>Egger</surname>
</string-name>, <string-name>
<given-names>G. D.</given-names>
<surname>Smith</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Schneider</surname>
</string-name>, and <string-name>
<given-names>C.</given-names>
<surname>Minder</surname>
</string-name>, &#x0201c;<article-title>Bias in Meta&#x02010;Analysis Detected by a Simple, Graphical Test</article-title>,&#x0201d; <source>BMJ (London)</source>
<volume>315</volume>, no. <issue>7109</issue> (<year>1997</year>): <fpage>629</fpage>&#x02013;<lpage>634</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0046"><label>46</label><mixed-citation publication-type="book" id="hsr270495-cit-0046">
<string-name>
<given-names>M.</given-names>
<surname>Borenstein</surname>
</string-name>, &#x0201c;<part-title>Comprehensive Meta&#x02010;Analysis Software</part-title>.&#x0201d; <source>Systematic Reviews in Health Research: Meta&#x02010;Analysis in Context</source> (<publisher-name>John Wiley &#x00026; Sons, Ltd</publisher-name>, <year>2022</year>). <edition>Third Edition</edition>, <fpage>535</fpage>&#x02013;<lpage>548</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="hsr270495-cit-0047">
<string-name>
<given-names>I. B.</given-names>
<surname>Leibiger</surname>
</string-name> and <string-name>
<given-names>P. O.</given-names>
<surname>Berggren</surname>
</string-name>, &#x0201c;<article-title>Sirt1: A Metabolic Master Switch That Modulates Lifespan</article-title>,&#x0201d; <source>Nature Medicine</source>
<volume>12</volume>, no. <issue>1</issue> (<year>2006</year>): <fpage>34</fpage>&#x02013;<lpage>36</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="hsr270495-cit-0048">
<string-name>
<given-names>Y.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, et al., &#x0201c;<article-title>Regulation of SIRT1 and its Roles in Inflammation</article-title>,&#x0201d; <source>Frontiers in Immunology</source>
<volume>13</volume>, no. <issue>March</issue> (<year>2022</year>): <fpage>1</fpage>&#x02013;<lpage>16</lpage>.</mixed-citation></ref><ref id="hsr270495-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="hsr270495-cit-0049">
<string-name>
<given-names>M.</given-names>
<surname>Kitada</surname>
</string-name> and <string-name>
<given-names>D.</given-names>
<surname>Koya</surname>
</string-name>, &#x0201c;<article-title>SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential</article-title>,&#x0201d; <source>Diabetes &#x00026; Metabolism Journal</source>
<volume>37</volume>, no. <issue>5</issue> (<year>2013</year>): <fpage>315</fpage>&#x02013;<lpage>325</lpage>.<pub-id pub-id-type="pmid">24199159</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="hsr270495-cit-0050">
<string-name>
<given-names>J. H.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>M. Y.</given-names>
<surname>Song</surname>
</string-name>, <string-name>
<given-names>E. K.</given-names>
<surname>Song</surname>
</string-name>, et al., &#x0201c;<article-title>Overexpression of SIRT1 Protects Pancreatic &#x003b2;&#x02010;cells Against Cytokine Toxicity by Suppressing the Nuclear Factor&#x02010;&#x003ba;B Signaling Pathway</article-title>,&#x0201d; <source>Diabetes</source>
<volume>58</volume>, no. <issue>2</issue> (<year>2009</year>): <fpage>344</fpage>&#x02013;<lpage>351</lpage>.<pub-id pub-id-type="pmid">19008341</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="hsr270495-cit-0051">
<string-name>
<given-names>S.</given-names>
<surname>Fr&#x000f6;jd&#x000f6;</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Durand</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Molin</surname>
</string-name>, et al., &#x0201c;<article-title>Phosphoinositide 3&#x02010;kinase as a Novel Functional Target for the Regulation of the Insulin Signaling Pathway by SIRT1</article-title>,&#x0201d; <source>Molecular and Cellular Endocrinology</source>
<volume>335</volume>, no. <issue>2</issue> (<year>2011</year>): <fpage>166</fpage>&#x02013;<lpage>176</lpage>.<pub-id pub-id-type="pmid">21241768</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="hsr270495-cit-0052">
<string-name>
<given-names>M.</given-names>
<surname>Kitada</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Ogura</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Monno</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Koya</surname>
</string-name>, &#x0201c;<article-title>Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function</article-title>,&#x0201d; <source>Frontiers in Endocrinology</source>
<volume>10</volume> (<year>2019</year>), <pub-id pub-id-type="doi">10.3389/fendo.2019.00187</pub-id>.</mixed-citation></ref><ref id="hsr270495-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="hsr270495-cit-0053">
<string-name>
<given-names>L.</given-names>
<surname>Qiao</surname>
</string-name> and <string-name>
<given-names>J.</given-names>
<surname>Shao</surname>
</string-name>, &#x0201c;<article-title>SIRT1 Regulates Adiponectin Gene Expression Through Foxo1&#x02010;C/enhancer&#x02010; Binding Protein &#x003b1; Transcriptional Complex</article-title>,&#x0201d; <source>Journal of Biological Chemistry</source>
<volume>281</volume>, no. <issue>52</issue> (<year>2006</year>): <fpage>39915</fpage>&#x02013;<lpage>39924</lpage>.<pub-id pub-id-type="pmid">17090532</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="hsr270495-cit-0054">
<string-name>
<given-names>X. Q.</given-names>
<surname>Deng</surname>
</string-name>, <string-name>
<given-names>L. L.</given-names>
<surname>Chen</surname>
</string-name>, and <string-name>
<given-names>N. X.</given-names>
<surname>Li</surname>
</string-name>, &#x0201c;<article-title>The Expression of SIRT1 in Nonalcoholic Fatty Liver Disease Induced by High&#x02010;Fat Diet in Rats</article-title>,&#x0201d; <source>Liver International</source>
<volume>27</volume>, no. <issue>5</issue> (<year>2007</year>): <fpage>708</fpage>&#x02013;<lpage>715</lpage>.<pub-id pub-id-type="pmid">17498258</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="hsr270495-cit-0055">
<string-name>
<given-names>S. V.</given-names>
<surname>De Kreutzenberg</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Ceolotto</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Papparella</surname>
</string-name>, et al., &#x0201c;<article-title>Downregulation of the Longevity&#x02010;Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms</article-title>,&#x0201d; <source>Diabetes</source>
<volume>59</volume>, no. <issue>4</issue> (<year>2010</year>): <fpage>1006</fpage>&#x02013;<lpage>1015</lpage>.<pub-id pub-id-type="pmid">20068143</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="hsr270495-cit-0056">
<string-name>
<given-names>M. P.</given-names>
<surname>Gillum</surname>
</string-name>, <string-name>
<given-names>M. E.</given-names>
<surname>Kotas</surname>
</string-name>, <string-name>
<given-names>D. M.</given-names>
<surname>Erion</surname>
</string-name>, et al., &#x0201c;<article-title>SirT1 Regulates Adipose Tissue Inflammation</article-title>,&#x0201d; <source>Diabetes</source>
<volume>60</volume>, no. <issue>12</issue> (<year>2011</year>): <fpage>3235</fpage>&#x02013;<lpage>3245</lpage>.<pub-id pub-id-type="pmid">22110092</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="hsr270495-cit-0057">
<string-name>
<given-names>F.</given-names>
<surname>Bartoli&#x02010;Leonard</surname>
</string-name>, <string-name>
<given-names>F. L.</given-names>
<surname>Wilkinson</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Schiro</surname>
</string-name>, <string-name>
<given-names>F. S.</given-names>
<surname>Inglott</surname>
</string-name>, <string-name>
<given-names>M. Y.</given-names>
<surname>Alexander</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Weston</surname>
</string-name>, &#x0201c;<article-title>Suppression of SIRT1 in Diabetic Conditions Induces Osteogenic Differentiation of Human Vascular Smooth Muscle Cells va RUNX2 Signalling</article-title>,&#x0201d; <source>Scientific Reports</source>
<volume>9</volume>, no. <issue>1</issue> (<year>2019</year>): <fpage>878</fpage>.<pub-id pub-id-type="pmid">30696833</pub-id>
</mixed-citation></ref><ref id="hsr270495-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="hsr270495-cit-0058">
<string-name>
<given-names>M. L.</given-names>
<surname>Balestrieri</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Servillo</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Esposito</surname>
</string-name>, et al., &#x0201c;<article-title>Poor Glycaemic Control in Type 2 Diabetes Patients Reduces Endothelial Progenitor Cell Number by Influencing SIRT1 Signalling via Platelet&#x02010;Activating Factor Receptor Activation</article-title>,&#x0201d; <source>Diabetologia</source>
<volume>56</volume>, no. <issue>1</issue> (<year>2013</year>): <fpage>162</fpage>&#x02013;<lpage>172</lpage>.<pub-id pub-id-type="pmid">23070058</pub-id>
</mixed-citation></ref></ref-list></back></article>